Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?

Lung Cancer

Volumn 49, Issue 1, 2005, Pages 109-115

  Carolan, Hannah ^a   Sun, Alexander Y ^a   Bezjak, Andrea ^a   Yi, Qi Long ^b   Payne, David ^a   Kane, Gabrielle ^a   Waldron, John ^a   Leighl, Natasha ^b   Feld, Ronald ^b   Burkes, Ronald ^b   Keshavjee, Shaf ^b   Shepherd, Frances ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Brain metastases; Combined modality therapy; Early detection; Locally advanced non small cell lung cancer; Lung cancer; Prophylactic cranial irradiation

Indexed keywords

BRAIN DYSFUNCTION; BRAIN METASTASIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CONFERENCE PAPER; DATA BASE; EARLY DIAGNOSIS; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SKULL IRRADIATION; TREATMENT OUTCOME;

AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 20444398157     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.12.004     Document Type: Conference Paper

References (28)

1. M. Stuschke, W. Eberhardt, C. Pottgen, G. Stamatis, H. Wilke, and G. Stuben Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects J Clin Oncol 17 9 1999 2700 2709
2. T.J. Robnett, M. Machtay, J.P. Stevenson, K.M. Algazy, and S.M. Hahn Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small cell lung carcinoma J Clin Oncol 19 5 2001 1344 1349
3. F. Andre, D. Grunenwald, J.L. Pujol, P. Girard, A. Dujon, and L. Brouchet Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer 91 12 2001 2394 2400
4. A. Law, D.D. Karp, T. Dipetrillo, and B.T. Daly Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced non-small cell lung carcinoma Cancer 92 1 2001 160 164
5. K.S. Albain, V.W. Rusch, J.J. Crowley, T.W. Rice, A.T. Turrisi 3rd, and J.K. Weick Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for Stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 8 1995 1880 1892
6. P. Kumar, J. Herndon 2nd, M. Langer, L.J. Kohman, A.D. Elias, and F.C. Kass Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic Stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935 Cancer 77 11 1996 2393 2399
7. R.O. Dillman, S.L. Seagren, K.J. Propert, J. Guerra, W.L. Eaton, and M.C. Perry A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small cell lung cancer N Engl J Med 323 14 1990 940 945
8. W.T. Sause, C. Scott, S. Taylor, D. Johnson, R. Livingston, and R. Komaki Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer J Natl Cancer Inst 87 3 1995 198 205
9. J.D. Cox, C.B. Scott, R.W. Byhardt, B. Emami, A.H. Russell, and K.K. Fu Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of Radiation Therapy Oncology Group (RTOG) trials Int J Radiat Oncol Biol Phys 43 3 1999 505 509
10. K. Furuse, M. Fukuoka, M. Kawahara, H. Nishikawa, Y. Takada, and S. Kudoh Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable Stage III non-small cell lung cancer J Clin Oncol 17 9 1999 2692 2699
11. A. Auperin, R. Arriagada, J.P. Pignon, C. Le Pechoux, A. Gregor, and R.J. Stephens Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group N Engl J Med 341 7 1999 476 484
12. A.H. Russell, T.E. Pajak, H.M. Selim, J.C. Paradelo, K. Murray, and P. Bansal Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 21 3 1991 637 643
13. J.D. Cox, K. Stanley, Z. Petrovich, C. Paig, and R. Yesner Cranial irradiation in cancer of the lung of all cell types JAMA 245 5 1981 469 472
14. T. Umsawasdi, M. Valdivieso, T.T. Chen, H.T. Barkley Jr., D.J. Booser, and D.F. Chiuten Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer J Neurooncol 2 3 1984 253 259
15. K.S. Albain Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for Stage IIIA (pN2) non-small cell lung cancer (NSCLC): first outcome analysis of North American Intergroup Trial 0139 (RTOG 93-09) Lung Cancer 41 Suppl. 2 2003 4
16. G.L. Ceresoli, M. Reni, G. Chiesa, A. Carretta, S. Schipani, and P. Passoni Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis Cancer 95 3 2002 605 612
17. V. Westeel Risk of brain metastases in non-metastatic non-small cell lung cancer Lung Cancer 41 Suppl. 2 2003 21
18. T.A. D'Amico, T.A. Aloia, M.B. Moore, D.H. Conlon, J.E. Herndon 2nd, and M.S. Kinch Predicting the sites of metastases from lung cancer using molecular biologic markers Ann Thorac Surg 72 4 2001 1144 1148
19. M.S. Kinch, M.B. Moore, and D.H. Harpole Jr. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival Clin Cancer Res 9 2 2003 613 618
20. B. Keith, M. Vincent, L. Stitt, A. Tomiak, R. Malthaner, and E. Yu Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small cell lung cancer Am J Clin Oncol 25 6 2002 583 587
21. P. Rodrigus, P. de Brouwer, and E. Raaymakers Brain metastases and non-small cell lung cancer. Prognostic factors and correlation with survival after irradiation Lung Cancer 32 2 2001 129 136
22. R.A. Patchell, P.A. Tibbs, W.F. Regine, R.J. Dempsey, M. Mohiuddin, and R.J. Kryscio Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial JAMA 280 17 1998 1485 1489
23. Y. Ohta, M. Oda, Y. Tsunezuka, N. Uchiyama, H. Nishijima, and T. Takanaka Results of recent therapy for non-small cell lung cancer with brain metastasis as the initial relapse Am J Clin Oncol 25 5 2002 476 479
24. B. Li, J. Yu, M. Suntharalingam, A.S. Kennedy, P.P. Amin, and Z. Chen Comparison of three treatment options for single brain metastasis from lung cancer Int J Cancer 90 1 2000 37 45
25. Y.S. Kim, D. Kondziolka, J.C. Flickinger, and L.D. Lunsford Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain Cancer 80 11 1997 2075 2083
26. J.M. Kurtz, R. Gelber, L.W. Brady, R.J. Carella, and J.S. Cooper The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 7 7 1981 891 895
27. K. Yokoi, N. Miyazawa, and T. Arai Brain metastasis in resected lung cancer: value of intensive follow-up with computed tomography Ann Thorac Surg 61 2 1996 546 550 [discussion 51]
28. R. Felletti, R.L. Souhami, S.G. Spiro, D.M. Geddes, J.S. Tobias, and B.S. Mantell Social consequences of brain or liver relapse in small cell carcinoma of the bronchus Radiother Oncol 4 4 1985 335 339